U.S. FDA advisers recommend COVID-19 boosters for 65 and older after rejecting broad approval
By Michael Erman, Julie Steenhuysen and Manojna Maddipatla
Advisers to the U.S. Food and Drug Administration voted...
Subscribing is the best way to get our best stories immediately.